Upregulation of peroxisome proliferator-activated receptor-α and the lipid metabolism pathway promotes carcinogenesis of ampullary cancer

Abstract

Ampullary cancer is a rare periampullary cancer currently with no targeted therapeutic agent. It is important to develop a deeper understanding of the carcinogenesis of ampullary cancer. We attempted to explore the characteristics of ampullary cancer in our dataset and a public database, followed by a search for potential drugs. We used a bioinformatics pipeline to analyze complementary (c)DNA microarray data of ampullary cancer and surrounding normal duodenal tissues from five patients. A public database from the National Center for Biotechnology Information Gene Expression Omnibus (NCBI GEO) was applied for external validation. Bioinformatics tools used included the Gene Set Enrichment Analysis (GSEA), Database for Annotation, Visualization and Integrated Discovery (DAVID), MetaCore, Kyoto Encyclopedia of Genes and Genomes (KEGG), Hallmark, BioCarta, Reactome, and Connectivity Map (CMap). In total, 9097 genes were upregulated in the five ampullary cancer samples compared to normal duodenal tissues. From the MetaCore analysis, genes of peroxisome proliferator-activated receptor alpha ( PPARA ) and retinoid X receptor ( RXR )-regulated lipid metabolism were overexpressed in ampullary cancer tissues. Further a GSEA of the KEGG, Hallmark, Reactome, and Gene Ontology databases revealed that PPARA and lipid metabolism-related genes were enriched in our specimens of ampullary cancer and in the NCBI GSE39409 database. Expressions of PPARA messenger (m)RNA and the PPAR-α protein were higher in clinical samples and cell lines of ampullary cancer. US Food and Drug Administration (FDA)-approved drugs, including alvespimycin, trichostatin A (a histone deacetylase inhibitor), and cytochalasin B, may have novel therapeutic effects in ampullary cancer patients as predicted by the CMap analysis. Trichostatin A was the most potent agent for ampullary cancer with a half maximal inhibitory concentration of < 0.3 μM. According to our results, upregulation of PPARA and lipid metabolism-related genes are potential pathways in the carcinogenesis and development of ampullary cancer. Results from the CMap analysis suggested potential drugs for patients with ampullary cancer.

Prognostic and Genomic Analysis of Proteasome 20S Subunit Alpha (PSMA) Family Members in Breast Cancer

“…Delays in diagnosis and treatment that worsen the patient’s outcomes, along with the enormous burdens resulting from long-term and high-cost therapies, have once again undisputedly driven BRCA to become a major public health concern for scientists [ 55 , 56 , 57 , 58 , 59 ]. Clinical practice reveals that the heterogeneity of this disease, observed in both staging systems and histopathologic classification based on molecular standpoints, may complicate the accurate stratification and challenge the selection of respective therapeutic strategies [ 60 , 61 , 62 , 63 ]. Despite years of extraordinary efforts to enhance our knowledge of its biology and improve surgical treatments and chemotherapies, patient prognoses with advanced BRCA have not substantially improved.…”

Potential Prognostic Biomarkers of OSBPL Family Genes in Patients with Pancreatic Ductal Adenocarcinoma

“…The second part determined the biological processes, disease biomarker networks, and breast neoplasm cell-cell signaling pathways using a MetaCore analysis. Furthermore, a GO analysis was also implemented to describe genes and gene products from three categories: cell compositions, molecular functions (MFs), and biological processes (BPs) [ 38 , 39 , 40 ].…”

Analysis of LAGEs Family Gene Signature and Prognostic Relevance in Breast Cancer

“…The second part determined the biological processes, disease biomarker networks, and breast neoplasm cell-cell signaling pathways using the MetaCore analysis ( , accessed on 30 November 2020). Furthermore, a gene ontology (GO) analysis was also implemented to describe genes and gene products from three categories: cell composition, molecular function, and biological processes [ 41 , 42 , 43 ]. The source database for integrating and interpreting genomic information and chemical and systems information was The Kyoto Encyclopedia of Genes and Genomes (KEGG).…”